What Is NewSelf Semaglutide Plus⁺?
NewSelf GLP-1's Semaglutide Plus⁺ combines compounded semaglutide — the same active molecule as Ozempic and Wegovy — with either Cyanocobalamin (Vitamin B12) or Glycine. This is not a marketing gimmick: there is a legitimate clinical rationale for both additions. Brand-name Ozempic and Wegovy do not include B12 or Glycine — the enhancement is exclusive to compounded formulations and is one way the NewSelf program's pharmacy partners differentiate their products.
⚡ Limited Time: Free Overnight Shipping
Get NewSelf Semaglutide Plus⁺ with B12 or Glycine for $99.97/mo — all dosages same price, free overnight shipping.
✓ All dosages same price · ✓ Full refund if declined · ✓ No membership fees
Why B12 (Cyanocobalamin) Is Added
B12 (Cyanocobalamin) is an essential water-soluble vitamin involved in neurological function, red blood cell formation, and energy metabolism. The clinical rationale for including B12 in GLP-1 formulations is legitimate: GLP-1 receptor agonists significantly reduce appetite and caloric intake — and reduced food intake can decrease B12 absorption over time, particularly in patients already at borderline B12 status or with absorption challenges (older adults, vegetarians, those on metformin). The B12 addition proactively supports neurological health and energy metabolism during GLP-1-driven caloric restriction.
What Glycine Does
Glycine is a non-essential amino acid with roles in protein synthesis, neurotransmitter regulation (inhibitory glycine receptor), and collagen production. In compounded GLP-1 formulations, Glycine primarily functions as a pharmaceutical stabilizer — helping maintain the semaglutide molecule's stability in aqueous solution. Some compound pharmacies also cite Glycine's role in sleep quality and cognitive function, though these benefits are secondary to the formulation stability role.
Does the B12 Addition Change Weight Loss?
No published clinical trial directly compares B12-enhanced semaglutide to semaglutide alone for weight loss outcomes. The B12 is not expected to change the GLP-1 mechanism or enhance weight-loss efficacy. The STEP-1 trial's 14.9% average weight loss figure was achieved without B12. The B12 addition is a nutritional support layer during metabolically intensive weight loss — not an active co-agent. Evaluate NewSelf's compounded GLP-1 primarily on its semaglutide component's established clinical evidence. See our clinical sources.